Skip to main content

andexanet alfa

Generic: andexanet alfa·Brand: Andexxa

andexanet alfa: 2 clinical trials tracked.

andexanet alfa evidence translation

What we can confirm

2 tracked trials

No verified listed developer

What it means

AI will separate confirmed drug evidence from unknown company context.

What to watch

Watch trial status, endpoints, and the next source-backed update.
BioSniper AIPage evidence connected

Prepared research question

What is verified about andexanet alfa, and what remains unknown?

Run cited research

Traceable citations · Unknowns marked

See linked entities and source evidence2 indications · 1 study sponsors
Clinical Trials (2)

A Phase I, Randomized, Single-blind, Placebo-controlled Study to Further Characterize Andexanet Posology and Assess the Interaction Between Andexanet and Subsequent Enoxaparin in Healthy Participants

NCT07312851·Phase 1·AZN
Completed

Primary endpoint: Anti-Factor (F) Xa activity

InterventionalRandomizedsingle191 enrolledStarted 2026-01Completion 2026-062 sites · Germany, United KingdomAstraZeneca

Retrospective Real World Evidence Study to Describe Characteristics and Outcomes in Dutch Patients Admitted to the Hospital With a Factor Xa Inhibitor-associated Bleeding Treated With Andexanet Alfa

Completed

Primary endpoint: Patient characteristics

Observational217 enrolledStarted 2023-10Completion 2025-111 site · NetherlandsAstraZeneca